Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Mitomycin × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 12 Non-Muscle Invasive Bladder Neoplasms 9 Carcinoma, Transitional Cell 7 Stomach Neoplasms 4 Anus Neoplasms 4 Pancreatic Neoplasms 3 Carcinoma, Hepatocellular 3 Peritoneal Neoplasms 2 Liver Neoplasms 2 Colorectal Neoplasms 2 Appendiceal Neoplasms 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pseudomyxoma Peritonei 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Recurrence, Local 1 Neoplasm Metastasis 1 Mycobacterium Infections 1 Gastrointestinal Neoplasms 1 Dermatitis 1 Carcinoma in Situ 1 Carcinoma 1 Anal Canal Carcinoma 1 Adenocarcinoma 1

Interventions

Pemetrexed 12 Cisplatin 11 pembrolizumab 8 Carboplatin 6 Ipilimumab 5 Nivolumab 4 LMB-100 4 durvalumab 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 spartalizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡